Global AI hardware sold off on 2026-10-13. Three triggers hit together: an unverified CXMT 4F² DRAM claim, the Broadcom CEO's "casino" remark, and a reported 20% cost-cut order at Microsoft's cloud unit. The briefing's reverse-thinking lens separates narrative shocks (CXMT, with no yield data), flow shocks (Korean buyback expiry, SpaceX unlock) and fundamental shocks (5.21% 10-year yield, thinning cloud margins). It buys only where cash flow, buybacks or a verifiable thesis exist, which fits the abundance thesis through a capital-constrained patch.
Key signals
- KOSPI -5.46% on 2026-10-13 (-13.8% over five days). Samsung fell 7.4% and SK Hynix 10%. The briefing attributes this to flows: Samsung's buyback ended 10-06, SK Hynix's expires mid-October, and foreign investors have net sold over 200 trillion won this year.
- Rates are the macro backdrop. The US 10-year yield is 5.21% and the 30-year 5.56%. US September CPI is due 10-14, and TSMC's Q3 report on 10-15 (Q4 guidance consensus about $50.4B).
- Frontier model pricing converged at $2/$10 per million tokens. Google's Gemini 4 Argon opened 10-13 at that introductory price, rising to $4/$20 after 11-30. OpenAI's GPT-6.1 Sol is priced the same.
- Capital stress is showing in the AI buildout. Cipher Digital fell 12.8% after an $850M zero-coupon convertible, and Character.AI filed for Chapter 11 on 10-12 with Disney bidding $20M.
- Equal-weight tech rose 1.07% while the Philadelphia Semiconductor index fell. Money is rotating inside AI from semiconductors to cash-generating distribution layers.
By theme
AI
- Gemini 4 Argon, GPT-6.1 Sol and Anthropic's Haiku 5.5 launch put frontier prices at the same point. The briefing reads falling token prices plus surging usage as good for compute sellers (NVDA, TSM, AVGO) and distributors (GOOGL, MSFT), and bad for second-tier labs.
- Microsoft's reported 20% cost-cut order sits against FY26 capex of $115.9B (+80%) and cloud gross margin down from 68% to 65%. The briefing reads it as shifting budget to GPUs, not weak demand.
- Anthropic's reported multi-year IREN deal is unconfirmed by either side.
Robotics
- Humanoid news is mostly targets: Optimus weekly output of 1,000+ by year-end, UBTech's 10,000 units by 2030. None comes with delivery counts.
- Intuitive Surgical (ISRG) is the hardest asset in the theme. Q3 results are due 10-20 after the close, with US da Vinci procedure growth versus Q2's 12% the key test.
- Multiply Labs raised a $75M Series B with Teradyne and AstraZeneca as new investors, linking robotics and biomanufacturing.
Space
- SpaceX fell 4.2% on four items: a successful Falcon 9 launch, an FAA review of up to 456 launches a year, doubts over the $8B spectrum purchase, and a 328M-share unlock on 10-24.
- Rocket Lab's Neutron first flight may slip to 2027. Most space names sit 55–74% below their 52-week highs while insiders keep selling.
- Stoke Space raised a $1B Series E; Singapore-based Exosat has only an ITU filing and LOIs so far.
Biotech
- Regeneron's Pasatru showed zero new heterotopic ossification lesions from weeks 56–84. Beam's BEAM-301 data covers only six dosed patients, so the briefing flags binary risk.
- No AI-discovered drug has yet received full FDA approval (August tally). Recursion fell 4.4% and its stock is down 17% on the week.
- Venture money is moving from AI discovery toward delivery and manufacturing.
Hong Kong, A-shares and crypto
- The Hang Seng Tech index hit a new low of 4,050.9 intraday, near its "924" starting point. A-share PCB and CPO stocks surged on limit-ups while US optical names fell 6–10%. The briefing calls the A-share move an event pulse, not a trend start.
- BTC traded around 83,150, below the ETF holders' average cost of $84,340. About $800M of leveraged positions were liquidated, including tokenized SNDK contracts.
- MAS's stablecoin consultation closes 2026-10-16.
Rating highlights
| Ticker | Company | Call | Why |
|---|---|---|---|
| AVGO:NASDAQ | Broadcom | Buy | CEO bubble talk is governance positive; inside buy zone 354.34–360.14 |
| GOOGL:NASDAQ | Alphabet | Buy | Frontier pricing held at parity; lowest PE among the megacaps (17.8) |
| ISRG:NASDAQ | Intuitive Surgical | Buy | Hardest robotics asset; half position before 10-20 earnings |
| REGN:NASDAQ | Regeneron | Buy | Forward PE 12; Pasatru long-term evidence strengthens thesis |
| 0700:HKEX | Tencent | Buy (upgraded) | PE 14.5 at multi-year low; asymmetric payoff favors buying |
| MU:NASDAQ | Micron | Hold | Forward PE 4.6; price touched the 954.23 stop, no adding |
| NVDA:NASDAQ | NVIDIA | Hold | New buyers expanding; forward PE 14.5 lowest among peers |
| PLTR:NASDAQ | Palantir | Sell | Target below price, RSI 75.6, crowded; asymmetry unfavorable |
| ILMN:NASDAQ | Illumina | Sell | Target 11% below price; insiders cut 87% in six months |
| MRNA:NASDAQ | Moderna | Sell | Target 45% below price; +633% YTD without earnings support |
| FN:NYSE | Fabrinet | Sell | Institutions selling, below SMA200, stop 452.29 broken |
| SPCX:NASDAQ | SpaceX | Watch | 10-24 unlock and FAA review are two selling-pressure windows |
| 688836:SSE | Unitree | Watch | Volume priced in; target upside only 11%; margin test |
| 002747:SZSE | Estun | Sell | Consensus Sell; target below price |
Tenbagger radar
- The briefing contains no tenbagger radar section for 2026-10-14, so there was no change in the watch pool.
Risks to watch
- 10-14: ASML Q3 (guidance €11.0–12.0B revenue, 55–57% gross margin) and US September CPI.
- 10-15 / 10-16: TSMC Q3 and Q4 guidance. MAS stablecoin consultation closes 10-16.
- 10-20 to 10-30: ISRG (10-20), Meta and Tesla (10-21), Lam Research (10-21), Micron-linked names and SanDisk (10-30).
- 10-24 / 11-08: SpaceX 328M-share unlock, then Starship Flight 15 pencilled in for 11-08.
- Rates and capital: with the 10-year at 5.21%, debt-funded AI infrastructure such as CoreWeave, Cipher and Nebius is the most exposed.